Aderans Treats 100th Subject in Hair Regeneration Trials
Aderans Research Institute Inc (ARI), has achieved a significant milestone in Phase 2 of its cell-based hair regeneration study by treating the trial’s 100th hair loss subject. In the coming months, the study will double the number of participants. So far, the study has been conducted in eight US cities and will likely comprise up [...] [...more]
